Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on June 13, 2025
Westie Foundation Expands Canine Clinical Trial in Response to Worldwide Interest
EIN Presswire
·
June 13, 2025
Dog owners asked for their pets to be included in drug study in canines suffering from lung scarring HOUSTON, TX, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- The Westie Foundation of America (WFA), a 501(c)3 nonprofit organization dedicated to …
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
GlobeNewswire
·
June 13, 2025
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, …
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 13, 2025
LEXINGTON, Mass., June 13, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and …
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
GlobeNewswire
·
June 13, 2025
TTAM Commits to Comply with Company’s Privacy Policy and All Applicable Laws TTAM Commits to Adopting Additional Consumer Protections and Privacy Safeguards to Enhance Protections for Customer Data and Privacy No Changes to 23andMe’s Privacy Policy or …
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 13, 2025
SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in …
Hospital Bill Negotiators Are Saving Americans Millions
EIN Presswire
·
June 13, 2025
As medical debt surges nationwide, Goodbill is delivering powerful hospital bill reductions for health share members. AUSTIN, TX, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- In a healthcare system where over 80% of medical bills contain errors …
KFSHRC Advances Smart Hospital Transformation through AI and Emerging Technologies
GlobeNewswire
·
June 13, 2025
RIYADH, Saudi Arabia, June 13, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …
Worker Protection from Heat Stress: Now More Than Ever, It's Up to Employers to Do The Right Thing
GlobeNewswire
·
June 13, 2025
St. Paul, MN, June 13, 2025 (GLOBE NEWSWIRE) -- With federal cost-cutting and deregulation reshaping workplace safety oversight, the responsibility to protect workers from extreme heat is falling squarely on employers. While OSHA’s National Emphasis …
Southwest Houston Clinic Offers Specialized Women's Health Care Services
EIN Presswire
·
June 13, 2025
Benech Family Clinic -- (281) 909-0102 provides women's health services in Southwest Houston, TX, offering screenings and specialized care. SOUTHWEST HOUSTON, TX, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- Benech Family Clinic, located at 8622 S …
Stafford, TX Clinic Provides Laboratory & Diagnostic Tests For Comprehensive Care
EIN Presswire
·
June 13, 2025
Benech Family Clinic -- (281) 909 0102 offers laboratory …
Missouri City, TX Clinic Provides Comprehensive Primary Care Services
EIN Presswire
·
June 13, 2025
Benech Family Clinic -- (281) 909 0102 offers primary care in Missouri City, TX, providing preventative health services and walk-in appointments. MISSOURI CITY, HOUSTON, TX, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- Benech Family Clinic, …
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
GlobeNewswire
·
June 13, 2025
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy PolTREG established Immuthera (https://immuthera.bio/) in Delaware to expand its presence in the U.S. market. A Pre-IND application was submitted to …
The Dental Medical Convergence Announces Featured Article and Podcast Interview on KevinMD Highlighting Dangers of Dental Infections
GlobeNewswire
·
June 13, 2025
Eustis, Florida , June 13, 2025 (GLOBE NEWSWIRE) -- The Dental Medical Convergence, a nonprofit dedicated to educating the public about the link between oral health and systemic disease, announced today that KevinMD—widely recognized as social media’s …
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
GlobeNewswire
·
June 13, 2025
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchit’s Concurrent Financing
GlobeNewswire
·
June 13, 2025
VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- 1317229 B.C. Ltd. (“131” or the “Company”) and Launchit Solutions Inc. (“Launchit”) are pleased to announce that the Company, Launchit and 1001240330 Ontario Inc. (“Subco”), a wholly-owned …
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
GlobeNewswire
·
June 13, 2025
– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced annualized exacerbations in patients with eosinophilic-driven type 2 asthma – – Data supports ongoing Phase 2 …
InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
GlobeNewswire
·
June 13, 2025
MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical Device …
GT Biopharma Appoints New Member to its Board of Directors
GlobeNewswire
·
June 13, 2025
SAN FRANCISCO, CALIFORNIA, June 13, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer …
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
GlobeNewswire
·
June 13, 2025
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for …
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
GlobeNewswire
·
June 13, 2025
TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced that leading independent proxy …